GSK3B and prostate cancer: In contrast, the promotion of epithelial to mesenchymal transition (EMT) and acquisition of invasive and metastatic property in advanced prostate cancer cells is more dependent on GSK3β-mediated inhibition of β-catenin expression and destabilization of cell-cell contacts.